— Know what they know.
Not Investment Advice

ADGI NASDAQ

Adagio Therapeutics, Inc.
1W: -2.9% 1M: +23.7% 3M: +56.8% 1Y: -91.4%
$4.64
Last traded 2022-09-12 — delisted
NASDAQ · Healthcare · Biotechnology · $505.7M mcap · 54M float · 1.23% daily turnover

📊 Key Metrics

TTM
$58M
Revenue
+20.4% YoY
$-107M
Net Income
-369.6% YoY
$-110M
Free Cash Flow
+24.9% YoY
91.1%
Gross Margin
-320.8%
Op. Margin
-310.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-95.9%
ROA-69.7%
ROIC-302.5%

Valuation

P/E-11.8
P/B8.2
EV/EBITDA-24.3

Leverage

Debt/Equity0.05
Current Ratio5.87
Interest Cov.0.0x

Quality Scores

Piotroski F1/9
Altman Z17.88
Beneish M-2.31

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms